Ester Alves Belarmino
Research Subjects
Research Interests
Ester Alves Belarmino has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Amílcar Sabino Damazo
Research Center in Applied Morphology and Immunology (NuPMIA), Faculty of Medicine, University of Brasília (UnB), Brasília 70910-900, Brazil
1 shared publication - Ana Gabriela P. Meneses
Applied Immunology and Morphology Research Centre (NuPMIA), Morphology Area, Faculty of Medicine, University of Brasília (UnB), Brasília 70910-900, Brazil
1 shared publication - Ana Lúcia Carneiro Sarmento
Applied Immunology and Morphology Research Centre (NuPMIA), Morphology Area, Faculty of Medicine, University of Brasília (UnB), Brasília 70910-900, Brazil
1 shared publication - Andreanne Gomes Vasconcelos
People&Science Research, Development and Innovation Ltd., Technology Development Support Center (CDT), University of Brasília (UnB), Brasília 70910-000, Brazil
1 shared publication - Bruno Silva Sá
Applied Immunology and Morphology Research Centre (NuPMIA), Morphology Area, Faculty of Medicine, University of Brasília (UnB), Brasília 70910-900, Brazil
1 shared publication - Estéfani Alves Belarmino
Unified Education Center of the Federal District (UDF), Brasília 70390-045, Brazil
1 shared publication
Latest Publications
- Open Access
- 25 February 2026
- Published by MDPI AG in Proceedings
- Vol. 137 (1) , 39
Potential Cytotoxic Effect of the Drug Interaction Between 5-FU and Carcinogens: Histopathological Evidence in an In Vivo Murine Model
Introduction: 5-fluorouracil (5-FU) is the standard chemotherapeutic agent for treating squamous cell carcinoma (SCC)
- 25 February 2026
- Published by MDPI AG in Proceedings
- Vol. 137 (1) , 39
Open AccessPotential Cytotoxic Effect of the Drug Interaction Between 5-FU and Carcinogens: Histopathological Evidence in an In Vivo Murine Model
Introduction: 5-fluorouracil (5-FU) is the standard chemotherapeutic agent for treating squamous cell carcinoma (SCC)